Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial
DiscussionThere are no effective specific treatments for patients with ARDS and mortality rates remain high. The results from this study will provide evidence regarding the efficacy of a potential new therapeutic agent, FP-1201-lyo, in improving the clinical course and outcome for patients with moderate/severe ARDS.Trial registrationEuropean Union Clinical Trials Register, no:2014-005260-15. Registered on 15 July 2017. (Source: Trials)
Source: Trials - November 13, 2017 Category: Research Source Type: clinical trials
Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes
Condition: Relapsing-Remitting Multiple Sclerosis Intervention: Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2017 Category: Research Source Type: clinical trials
A Phase IIIb, Multicenter, International, Randomized, Assessor-blind, Active-controlled Parallel Arm Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Comparison to Interferon Beta-1a (REBIF ®) in Patients With RRMS
Condition: Multiple Sclerosis, Relapsing-Remitting Interventions: Drug: Enkorten; Drug: REBIF Sponsors: Bosnalijek D.D; MonitorCRO Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2017 Category: Research Source Type: clinical trials
Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes
Condition: Relapsing-Remitting Multiple Sclerosis Intervention: Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA Recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2017 Category: Research Source Type: clinical trials
